Appendix containing extended methods and supplementary tables and figures pertaining to the manuscript

In this study, we treated phylogenetically diverse Mycobacterium tuberculosis clinical strains to 65 unique drug combinations in two different host-like <i>in vitro</i> conditions. We observed a broad range of drug response phenotypes across the strains, with the most effective drug combinations varying greatly by strain and metabolic condition.